Tarsus Pharmaceuticals (TARS) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.74
-0.6
-0.45
-0.3

Details

Expected EPS
-0.349386
Actual EPS
-0.3
Surprise EPS
0.05
Surprise Percent
+14.14%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.3 per share for Q4 2025.

0 Comments

Share your thoughts